Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 9/20 | 0.50 |
| ▸ | CNR1 | P21554 | 8/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19257787 | 0.91 | CNR2 (0.58) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL19257793 | 0.88 | USP2 (0.67) | USP2CNR2CNR1ALDH1A1PLA2G2C | |
| SCHEMBL4925955 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL3391670 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL9328381 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL9329951 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL10520454 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL11300731 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL7800390 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 | |
| SCHEMBL19669679 | 0.85 | CNR2 (0.56) | USP2CNR2CNR1ALDH1A1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170233337-A1 | NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME | ARCHER DANIELS MIDLAND CO (IL) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233337-A1 | NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME | PNLIP, FFAR4, SPTLC2 | USP2 2124/4885CNR2 1830/4885CNR1 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.